Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
NW Genomic Laboratory hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
J Hum Genet. 2020 Mar;65(3):305-311. doi: 10.1038/s10038-019-0706-1. Epub 2019 Dec 12.
HARS2 encodes mitochondrial histidyl-tRNA synthetase (HARS2), which links histidine to its cognate tRNA in the mitochondrial matrix. Biallelic variants in HARS2 are associated with Perrault syndrome, a rare recessive condition characterized by sensorineural hearing loss in both sexes and primary ovarian insufficiency in 46,XX females. Some individuals with Perrault syndrome have a broader phenotypic spectrum with neurological features, including ataxia and peripheral neuropathy. Here, we report a recurrent variant in HARS2 in association with sensorineural hearing loss. In affected individuals from three unrelated families, the variant HARS2 c.1439G>A p.(Arg480His) is present as a heterozygous variant in trans to a putative pathogenic variant. The low prevalence of the allele HARS2 c.1439G>A p.(Arg480His) in the general population and its presence in three families with hearing loss, confirm the pathogenicity of this variant and illustrate the presentation of Perrault syndrome as nonsyndromic hearing loss in males and prepubertal females.
HARS2 编码线粒体组氨酰-tRNA 合成酶(HARS2),该酶在线粒体基质中将组氨酸与其对应的 tRNA 连接起来。HARS2 的双等位变异与 Perrault 综合征有关,这是一种罕见的隐性疾病,其特征为两性均存在感觉神经性听力损失和 46,XX 女性的原发性卵巢功能不全。一些具有 Perrault 综合征的个体具有更广泛的表型谱,包括神经特征,包括共济失调和周围神经病。在这里,我们报告了与感觉神经性听力损失相关的 HARS2 中的复发性变异。在来自三个无关家庭的受影响个体中,变体 HARS2 c.1439G>A p.(Arg480His)以反式的杂合变体存在于假定的致病性变体中。等位基因 HARS2 c.1439G>A p.(Arg480His)在普通人群中的低流行率及其在三个具有听力损失的家庭中的存在,证实了该变体的致病性,并说明了 Perrault 综合征作为男性和青春期前女性的非综合征性听力损失的表现。